<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Neurologic complications of bacterial meningitis in adults</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Neurologic complications of bacterial meningitis in adults</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Neurologic complications of bacterial meningitis in adults</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Daniel J Sexton, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Allan R Tunkel, MD, PhD, MACP</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Jennifer Mitty, MD, MPH</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Mar 06, 2020.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Bacterial meningitis continues to result in substantial morbidity and mortality despite the availability of effective antimicrobial therapy. The risk of dying or of developing complications is related to the age and general health of the patient, to the causative pathogen, to the severity and duration of illness at the time of presentation, and occasionally to delays in the initiation of antibiotic therapy. (See  <a class="medical medical_review" href="/d/html/1290.html" rel="external">"Initial therapy and prognosis of community-acquired bacterial meningitis in adults"</a>.)</p><p>Complications due to bacterial meningitis can be divided into systemic and neurologic. The neurologic complications of meningitis in adults will be reviewed here. The possible protective role of <a class="drug drug_general" data-topicid="9334" href="/d/drug information/9334.html" rel="external">dexamethasone</a> therapy to prevent neurologic complications in selected patients and more general issues, such as the clinical manifestations, diagnosis, treatment, and prognosis of bacterial meningitis in adults, as well as neurologic complications in neonates and children with bacterial meningitis, are discussed separately. (See  <a class="medical medical_review" href="/d/html/1299.html" rel="external">"Dexamethasone to prevent neurologic complications of bacterial meningitis in adults"</a> and  <a class="medical medical_review" href="/d/html/6026.html" rel="external">"Bacterial meningitis in children: Dexamethasone and other measures to prevent neurologic complications"</a> and  <a class="medical medical_review" href="/d/html/1287.html" rel="external">"Clinical features and diagnosis of acute bacterial meningitis in adults"</a> and  <a class="medical medical_review" href="/d/html/1290.html" rel="external">"Initial therapy and prognosis of community-acquired bacterial meningitis in adults"</a> and  <a class="medical medical_review" href="/d/html/1283.html" rel="external">"Treatment of bacterial meningitis caused by specific pathogens in adults"</a> and  <a class="medical medical_review" href="/d/html/6017.html" rel="external">"Bacterial meningitis in the neonate: Neurologic complications"</a> and  <a class="medical medical_review" href="/d/html/6000.html" rel="external">"Bacterial meningitis in children: Neurologic complications"</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">INCIDENCE</span><span class="headingEndMark"> — </span>Neurologic complications are not uncommon in adults with bacterial meningitis [<a href="#rid1">1-4</a>]. Neurologic sequelae have been estimated to occur in half of patients surviving bacterial meningitis [<a href="#rid5">5</a>]. In a review of 1412 episodes of community-acquired bacterial meningitis in adults, 21 percent of community-acquired episodes were associated with deficits that resulted in severe or moderate disability [<a href="#rid4">4</a>]. A higher rate of moderate to severe neurologic disability at discharge (34 percent) was noted in a study of 696 adults from the Netherlands [<a href="#rid3">3</a>]. The rate was much higher with pneumococcal compared with meningococcal meningitis (50 versus 12 percent). This finding is consistent with the generally worse outcomes and increased mortality seen with pneumococcal compared with other causes of bacterial meningitis. (See  <a class="medical medical_review" href="/d/html/1290.html" rel="external">"Initial therapy and prognosis of community-acquired bacterial meningitis in adults", section on 'Mortality'</a>.)</p><p>Persistent abnormal neurologic findings may include hearing loss, a major motor deficit, impaired cognition or speech, or cranial nerve palsy. Other neurologic complications are transient. The short duration of neurologic complications was illustrated in a report of 269 adults with community-acquired bacterial meningitis: a neurologic deficit developed in 21 percent during the course of the illness, but only 9 percent had a neurologic deficit at discharge [<a href="#rid1">1</a>]. </p><p class="headingAnchor" id="H3"><span class="h1">RISK FACTORS</span><span class="headingEndMark"> — </span>Baseline features have been used to estimate the individual risk for an adverse neurologic outcome in adults with bacterial meningitis in nine studies involving different populations and settings [<a href="#rid6">6</a>]. Most of these studies were hampered by methodologic problems related to study design, data collection, and/or analysis. As a result, no prognostic scoring system performs well enough to be useful by itself in patient management.</p><p>In observational studies, several features were associated with an unfavorable outcome: older age (&gt;65 years), hypotension, seizures, absence of otitis or sinusitis, alcoholism, tachycardia, lower score on the Glasgow Coma Scale, cranial nerve palsy, a cerebrospinal fluid white blood cell count of less than 1000 cells per microL, a positive blood culture, and a high serum C-reactive protein concentration [<a href="#rid1">1,4,7</a>]. Delay in initial antibiotics in the emergency department (median delay of four hours) was also associated with a worse outcome [<a href="#rid1">1</a>]. (See  <a class="medical medical_review" href="/d/html/1290.html" rel="external">"Initial therapy and prognosis of community-acquired bacterial meningitis in adults", section on 'Avoidance of delay'</a>.)</p><p>In addition to the above general risk factors, the rate of complications is greatest in patients with pneumococcal meningitis [<a href="#rid1">1-3</a>]. This may result in part from the persistence of potent biologic activity in the debris of killed bacteria [<a href="#rid8">8</a>]. The debris may stimulate the host inflammatory response, which in turn contributes to tissue damage. This phenomenon may also contribute to the reduction in neurologic complications seen in some patients with pneumococcal meningitis who are treated with <a class="drug drug_general" data-topicid="9334" href="/d/drug information/9334.html" rel="external">dexamethasone</a>. (See  <a class="medical medical_review" href="/d/html/1299.html" rel="external">"Dexamethasone to prevent neurologic complications of bacterial meningitis in adults"</a>.)</p><p class="headingAnchor" id="H4"><span class="h1">NEUROLOGIC COMPLICATIONS</span><span class="headingEndMark"> — </span>The neurologic complications of bacterial meningitis include:</p><p class="bulletIndent1"><span class="glyph">●</span>Impaired mental status</p><p class="bulletIndent1"><span class="glyph">●</span>Increased intracranial pressure and cerebral edema</p><p class="bulletIndent1"><span class="glyph">●</span>Seizures</p><p class="bulletIndent1"><span class="glyph">●</span>Focal neurologic deficits (eg, cranial nerve palsy, hemiparesis)</p><p class="bulletIndent1"><span class="glyph">●</span>Cerebrovascular abnormalities</p><p class="bulletIndent1"><span class="glyph">●</span>Sensorineural hearing loss</p><p class="bulletIndent1"><span class="glyph">●</span>Intellectual impairment</p><p></p><p>These complications may be sudden or gradual in onset and can appear at any time after the onset of symptoms, including after the completion of therapy. Impaired mental status is seen most often in patients at the time of presentation; seizures are more often seen during the early acute phase of illness. Although it may also occur early, sensorineural hearing loss is typically not appreciated until the patient has recovered from the acute illness. </p><p>Complications that occur after community-acquired meningitis are similar to those that occur after health care-associated meningitis although the pathogens most likely to cause these entities and the predisposing causes are different. For example, health care associated meningitis is more often due to staphylococci and gram-negative bacilli. Health care-associated meningitis is also most often associated with neurosurgical procedures and the placement of ventricular catheters. (See  <a class="medical medical_review" href="/d/html/1287.html" rel="external">"Clinical features and diagnosis of acute bacterial meningitis in adults", section on 'Presenting manifestations'</a> and  <a class="medical medical_review" href="/d/html/1302.html" rel="external">"Health care-associated meningitis and ventriculitis in adults: Clinical features and diagnosis"</a> and  <a class="medical medical_review" href="/d/html/1290.html" rel="external">"Initial therapy and prognosis of community-acquired bacterial meningitis in adults"</a>.)</p><p>Concern about both the mortality and morbidity of bacterial meningitis has led to the administration of adjunctive <a class="drug drug_general" data-topicid="9334" href="/d/drug information/9334.html" rel="external">dexamethasone</a> in selected patients. The data supporting this approach and the indications for dexamethasone therapy are discussed separately. (See  <a class="medical medical_review" href="/d/html/1299.html" rel="external">"Dexamethasone to prevent neurologic complications of bacterial meningitis in adults"</a>.)</p><p class="headingAnchor" id="H5"><span class="h2">Altered mental status</span><span class="headingEndMark"> — </span>Altered mental status is a common presenting feature in children and adults with bacterial meningitis. The major cause of severely diminished consciousness and coma is increased intracranial pressure (ICP).</p><p>In large studies of bacterial meningitis in adults, the incidence of altered mental status ranged from 71 to 83 percent at presentation [<a href="#rid1">1,2,4</a>]. In other series, coma (defined as Glasgow Coma score &lt;8;  (<a class="graphic graphic_table graphicRef81854" href="/d/graphic/81854.html" rel="external">table 1</a>)) was noted in 13 to 16 percent at presentation [<a href="#rid2">2-4</a>].</p><p class="headingAnchor" id="H6"><span class="h2">Increased intracranial pressure</span><span class="headingEndMark"> — </span>Many patients with bacterial meningitis develop increased ICP, which can produce a number of clinical signs or problems. Mild to moderate increases in ICP typically cause headache, confusion, irritability, nausea, and vomiting. More severe increases can produce one or more of the following:</p><p class="bulletIndent1"><span class="glyph">●</span>Altered mental status that can include coma</p><p class="bulletIndent1"><span class="glyph">●</span>Bradycardia with hypertension (the Cushing reflex)</p><p class="bulletIndent1"><span class="glyph">●</span>Papilledema, sometimes with loss of vision, which has been described in 4 to 9 percent of adults [<a href="#rid2">2,9</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>Cranial nerve palsy, particularly involving the abducens (VI) nerve [<a href="#rid9">9</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>Herniation of the cerebellar tonsils leading to death</p><p></p><p>(See  <a class="medical medical_review" href="/d/html/1659.html" rel="external">"Evaluation and management of elevated intracranial pressure in adults", section on 'Clinical manifestations'</a>.)</p><p>Raised intracranial pressure in patients with meningitis is primarily due to cerebral edema, which can be caused by vasogenic, cytotoxic, or interstitial mechanisms [<a href="#rid10">10</a>]. The net effect of these processes is the same: an increase in the intercellular fluid volume of the brain, leading to a rise in intracranial pressure.</p><p class="bulletIndent1"><span class="glyph">●</span>Vasogenic cerebral edema usually results from increased permeability of the blood-brain barrier, especially in the choroid plexus endothelium and the endothelium of the cerebral microvasculature.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Cytotoxic factors released from neutrophils and bacteria can directly produce cerebral edema.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The inflammation produced by the infection can impede the normal absorption of cerebrospinal fluid (CSF) from the subarachnoid space via the arachnoid villi.</p><p></p><p>Cerebral perfusion pressure, normally maintained by an autoregulatory mechanism, becomes dependent upon peripheral blood pressure during meningitis because autoregulation is impaired [<a href="#rid11">11,12</a>]. Cerebral edema itself can increase the intracranial pressure and secondarily reduce cerebral blood flow.</p><p>The possible presence of cerebral edema should be considered in all critically ill patients with meningitis. Treatment of intracranial hypertension can be initiated if the diagnosis is confirmed by neuroimaging studies or before the diagnosis has been established if it is strongly suspected on clinical grounds (eg, papilledema, fixed dilated pupil). <a class="drug drug_general" data-topicid="9334" href="/d/drug information/9334.html" rel="external">Dexamethasone</a> both decreases intracranial pressure and increases vascular perfusion. (See  <a class="medical medical_review" href="/d/html/1659.html" rel="external">"Evaluation and management of elevated intracranial pressure in adults"</a> and  <a class="medical medical_review" href="/d/html/1299.html" rel="external">"Dexamethasone to prevent neurologic complications of bacterial meningitis in adults"</a>.)</p><p class="headingAnchor" id="H7"><span class="h2">Seizures</span><span class="headingEndMark"> — </span>Seizures occur in 14 to 30 percent of adults with acute bacterial meningitis [<a href="#rid1">1-4,13</a>]. The pathogenesis of seizures in meningitis is not well understood. Although fever may be a cofactor in very young children, bacterial toxins or secondary neurochemical changes are presumably the cause of most seizures. In one study, for example, the occurrence of seizures correlated with colony counts of greater than 10<sup>7</sup> colony-forming units (CFU) in the CSF sample prior to treatment [<a href="#rid14">14</a>].</p><p>Seizures can be present at the time of admission or develop during hospitalization. In a prospective study of 696 episodes of community-acquired bacterial meningitis in adults, seizures occurred in 5 percent before admission and 15 percent after admission; the median time between admission and the first seizure was one day [<a href="#rid3">3,13</a>]. Seizures can be generalized or focal.</p><p>The incidence of seizures was significantly increased in patients with pneumococcal meningitis (24 versus 5 percent with meningococcal meningitis) [<a href="#rid3">3,13</a>]. Other risk factors for seizures in one of these series were a predisposing condition, tachycardia, low Glasgow Coma Scale score, focal neurologic deficits, a low CSF white blood cell (WBC) count (&lt;1000 cells/mm<sup>3</sup>), and a higher CSF protein level [<a href="#rid13">13</a>]. In a randomized, placebo-controlled trial of <a class="drug drug_general" data-topicid="9334" href="/d/drug information/9334.html" rel="external">dexamethasone</a> therapy, seizures were less likely in the treated patient group (5 versus 12 percent) [<a href="#rid2">2</a>].</p><p>Seizures during an episode of acute meningitis are often a poor prognostic sign in adults [<a href="#rid1">1,13</a>]. In one series of 696 patients with community-acquired bacterial meningitis, seizures were associated with a higher risk of neurologic deficits at hospital discharge (24 versus 6 percent) and death (41 versus 16 percent) [<a href="#rid13">13</a>]. All five patients with status epilepticus in this case series died.</p><p>Adults who have seizures during an episode of meningitis have a small but significant risk of seizures after recovery. In a follow-up study of 199 adult survivors of bacterial meningitis, patients with seizures during the acute illness were more likely to develop recurrent seizures within five years than those without seizures in the acute phase (8 versus 2 percent) [<a href="#rid15">15</a>]. A similar frequency of late recurrence (3 percent) was noted in another report [<a href="#rid16">16</a>].</p><p class="headingAnchor" id="H8"><span class="h2">Focal neurologic deficits</span><span class="headingEndMark"> — </span>Focal neurologic deficits are common complications of meningitis, with an incidence ranging from 20 to 50 percent [<a href="#rid2">2,3</a>]. The deficits include cranial nerve palsy, monoparesis, hemiparesis, gaze preference, visual field defects, aphasia, and ataxia, and most are present on admission [<a href="#rid2">2,3</a>]. </p><p>As with other neurologic complications, the rate of focal deficits is significantly higher in adults with pneumococcal meningitis compared with other pathogens. In one series, the incidence of focal deficits was 23 percent in pneumococcal meningitis compared with 9 and 3 percent in meningococcal meningitis and patients with negative cultures, respectively [<a href="#rid2">2</a>]. In another series, focal neurologic deficits were present at discharge in 65 percent of those with pneumococcal versus 33 percent with meningococcal meningitis [<a href="#rid3">3</a>].</p><p>Most focal deficits resolve with successful treatment of the meningitis, but long-term disability can occur.</p><p class="headingAnchor" id="H9"><span class="h3">Cranial nerve palsy</span><span class="headingEndMark"> — </span>Cranial nerve palsies have been described in 5 to 11 percent of patients and can occur alone or with other focal abnormalities [<a href="#rid2">2,3,9</a>]. .</p><p>Cranial nerve palsies can result from compression due to brain swelling or from perineuritis due to the adjacent meningeal inflammatory reaction [<a href="#rid9">9</a>]. The abducens (VI) nerve is the cranial nerve most commonly affected in meningitis, probably because its long intracranial segment adjacent to the brainstem is highly vulnerable to the elevated intracranial pressure and inflammatory reaction that can occur [<a href="#rid9">9</a>]. Cranial nerves III, IV, and VII also may become impaired in patients with meningitis. Deficits in all of these nerves are usually transient.</p><p>Bacterial meningitis can induce arachnoiditis around the optic nerve, which can lead to transient or permanent visual loss. Optic atrophy that results in irreversible total blindness is a rare complication of severe meningitis.</p><p>Another rare focal finding in patients with bacterial meningitis is cranial neuropathy due to reactivation of herpes zoster virus (Ramsay Hunt syndrome, also called herpes zoster oticus) [<a href="#rid17">17</a>]. (See  <a class="medical medical_review" href="/d/html/8327.html" rel="external">"Epidemiology, clinical manifestations, and diagnosis of herpes zoster", section on 'Ramsay Hunt syndrome (herpes zoster oticus)'</a>.)</p><p class="headingAnchor" id="H10"><span class="h3">Hemiparesis</span><span class="headingEndMark"> — </span>Other focal neurologic signs that may occur in bacterial meningitis include hemiparesis or quadriparesis. The reported incidence of hemiparesis has ranged from 4 to 13 percent [<a href="#rid2">2,3,9</a>]. .</p><p class="headingAnchor" id="H11"><span class="h2">Cerebrovascular complications</span><span class="headingEndMark"> — </span>Thrombosis, vasculitis, acute cerebral hemorrhage, and mycotic aneurysm formation of large, medium, or small cerebral vessels are potential complications of bacterial meningitis. These diverse processes can manifest similarly as a focal abnormality, such as hemiparesis [<a href="#rid9">9,18</a>].</p><p>In a prospective study of 86 adults with bacterial meningitis, cerebral angiography was performed in 27 (31 percent) because one or more of the following findings were present: focal neurologic deficits, abnormalities on computed tomographic (CT) scanning, or persistent coma after three days of antibiotic therapy [<a href="#rid18">18</a>]. Abnormal angiograms were found in 13 of these 27 patients; the abnormal findings included:</p><p class="bulletIndent1"><span class="glyph">●</span>Vessel wall irregularities and focal dilatations</p><p class="bulletIndent1"><span class="glyph">●</span>Arterial occlusions</p><p class="bulletIndent1"><span class="glyph">●</span>Focal arterial bleeding</p><p class="bulletIndent1"><span class="glyph">●</span>Thrombosis of the superior sagittal and cortical veins</p><p></p><p>In an observational study of 696 patients, cerebral infarction occurred in 174 (25 percent) episodes [<a href="#rid19">19</a>]. Patients with cerebral infarction were older and often presented with predisposing conditions such as otitis and/or sinusitis or an immunocompromised state. Unfavorable outcomes occurred more often in patients with cerebral infarction (62 versus 25 percent of patients without cerebral infarction; odds ratio 3.37, 95% CI 2.19-5.21). Lower CSF white cell counts and high erythrocyte sedimentation rate were found to be independent risk factors for cerebral infarction.</p><p>Another report describes a series of six patients who developed cerebral thrombosis affecting the brainstem and/or thalamus as a subacute complication of pneumococcal meningitis 7 to 19 days after initial presentation [<a href="#rid20">20</a>]. All patients had received <a class="drug drug_general" data-topicid="9334" href="/d/drug information/9334.html" rel="external">dexamethasone</a> initially, and five were treated again with high-dose steroids upon deterioration. Two patients survived with moderate to severe disability. Postmortem studies on two patients revealed thrombosis of penetrating arteries without evidence of vasculitis. In another study of 120 patients with community-acquired bacterial meningitis, delayed cerebral injury was seen in five patients, all of whom had received steroids within four hours of antibiotics [<a href="#rid21">21</a>].</p><p>Among 68 patients admitted to a neurologic intensive care unit with bacterial meningitis, a reduced level of consciousness at the time of admission and a low white blood cell count in the cerebrospinal fluid were found to be predictive factors for cerebral infarction [<a href="#rid22">22</a>].</p><p>A number of other rare cerebrovascular complications have been described in isolated reports. These include hemorrhagic stroke [<a href="#rid9">9,23</a>] and thrombotic infarction and/or subarachnoid hemorrhage into the brainstem [<a href="#rid24">24</a>]. Hemorrhagic strokes presumably occur when the inflammatory reaction in the subarachnoid space produces either vessel erosion or aneurysm formation.</p><p class="headingAnchor" id="H12"><span class="h2">Sensorineural hearing loss</span><span class="headingEndMark"> — </span>Sensorineural hearing loss may be subtle or inapparent during the early phases of infection. It may be transient or permanent. Transient hearing loss is usually secondary to a conductive disturbance, whereas permanent hearing loss can result from damage to the eighth cranial nerve, cochlea, or labyrinth induced by direct bacterial invasion and/or the inflammatory response elicited by the infection [<a href="#rid25">25-28</a>].</p><p>Studies in adults have shown hearing loss in 12 to 14 percent, with a higher rate in pneumococcal meningitis [<a href="#rid2">2,3,29</a>]. The following observations illustrate the range of findings:</p><p class="bulletIndent1"><span class="glyph">●</span>Among 119 survivors in the placebo group in a randomized controlled trial evaluating the efficacy of <a class="drug drug_general" data-topicid="9334" href="/d/drug information/9334.html" rel="external">dexamethasone</a>, hearing loss was present at eight weeks after admission in 12 percent [<a href="#rid2">2</a>]. As with most other neurologic complications, the incidence of hearing loss was greater in patients with <em>Streptococcus pneumoniae</em> infection than in those with <em>Neisseria meningitidis</em> or negative cultures (21 versus 11 and 4 percent, respectively).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Similar results were noted in the series of 696 adults with bacterial meningitis [<a href="#rid3">3</a>]. Among the 550 survivors to discharge, hearing loss was present in 14 percent, with a higher rate in pneumococcal compared with meningococcal meningitis (22 versus 8 percent).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In a retrospective study based upon a national registry, among 240 patients with pneumococcal meningitis who underwent audiometry, 129 (54 percent) had a hearing deficit [<a href="#rid30">30</a>]. Fifty of the 129 (39 percent) patients with a hearing deficit were not suspected of having a hearing deficit at hospital discharge. Of the 240 patients, 16 (7 percent) had profound unilateral hearing loss and another 16 (7 percent) had profound bilateral hearing loss. Using multivariate analysis, risk factors for hearing loss were advanced age, female gender, and certain serotypes; serotypes 6B and 14 were associated with a lower risk of hearing loss than serotype 12F.</p><p></p><p>A mouse model of pneumococcal meningitis suggested a role for the toll-like receptor-associated adapter molecule MyD88 in the development of cochlear inflammation and hearing loss [<a href="#rid31">31</a>].</p><p class="headingAnchor" id="H13"><span class="h2">Intellectual impairment</span><span class="headingEndMark"> — </span>Neuropsychological impairment is common in survivors of bacterial meningitis. A meta-analysis of three trials including 155 adult survivors of bacterial meningitis found that cognitive impairment occurred in 32 percent of patients [<a href="#rid32">32</a>]. The meta-analysis found no difference in cognitive impairment between survivors of pneumococcal and meningococcal meningitis, although two of the studies included found worse cognitive outcomes in patients with pneumococcal disease [<a href="#rid33">33,34</a>]. <a class="drug drug_general" data-topicid="9334" href="/d/drug information/9334.html" rel="external">Dexamethasone</a> does not appear to alter the incidence of cognitive impairment [<a href="#rid32">32,34</a>]. (See  <a class="medical medical_review" href="/d/html/1299.html" rel="external">"Dexamethasone to prevent neurologic complications of bacterial meningitis in adults"</a>.)</p><p class="headingAnchor" id="H28349379"><span class="h2">Hydrocephalus</span><span class="headingEndMark"> — </span>Several studies have reported that hydrocephalus may occur in adults as well as in children with bacterial meningitis. Most patients with this complication have a communicating form of hydrocephalus, although some patients have obstructive (noncommunicating) hydrocephalus. Among adult patients with community-onset bacterial meningitis, the reported incidence of this complication has ranged from 3 to 21 percent [<a href="#rid35">35-37</a>]. No study has been adequately powered to reliably identify predictive factors for this relatively uncommon but important complication.</p><p class="headingAnchor" id="H14"><span class="h2">Unusual complications</span><span class="headingEndMark"> — </span>A variety of other neurologic complications rarely occur in adults with bacterial meningitis:</p><p class="bulletIndent1"><span class="glyph">●</span>Extra-axial fluid collections that are infected (subdural empyemas) or sterile (subdural effusions or hygromas). Drainage is mandatory if subdural empyema develops. Detecting subdural empyemas and distinguishing them from sterile fluid collections requires correlation between clinical and imaging findings.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Spinal cord complications such as transverse myelitis or infarction, presumably as a direct result of local vascular changes with secondary cord ischemia [<a href="#rid38">38</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Brain abscesses and focal cerebritis may be causes of or complications of meningitis. When they are complications of meningitis, they occur with higher frequency in patients infected with certain uncommon causes of meningitis such as <em>Enterobacter</em> or <em>Citrobacter</em> spp [<a href="#rid25">25</a>] and tend to occur in the frontal or temporal lobes at the grey-white matter junction [<a href="#rid39">39</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Aneurysm formation of focal intracranial vessels, presumably secondary to inflammatory changes in the blood vessel wall [<a href="#rid40">40</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Ventriculitis, which may manifest as ependymal thickening and enhancement, generalized or segmental ventricular dilatation, and debris in the dependent portions of the ventricles by CT or magnetic resonance imaging [<a href="#rid39">39</a>].</p><p></p><p class="headingAnchor" id="H1309286873"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/104441.html" rel="external">"Society guideline links: Bacterial meningitis in adults"</a> and  <a class="medical medical_society_guidelines" href="/d/html/126560.html" rel="external">"Society guideline links: Hearing loss and hearing disorders in adults"</a>.)</p><p class="headingAnchor" id="H8265917"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)</p><p class="bulletIndent1"><span class="glyph">●</span>Basics topic (see  <a class="medical medical_basics" href="/d/html/16956.html" rel="external">"Patient education: Bacterial meningitis (The Basics)"</a>)</p><p></p><p class="headingAnchor" id="H9802243"><span class="h1">SUMMARY</span></p><p class="bulletIndent1"><span class="glyph">●</span>Bacterial meningitis continues to result in substantial morbidity and mortality despite the availability of effective antimicrobial therapy. The risk of dying or of developing complications is related to the age and general health of the patient, the causative pathogen, the severity and duration of illness at the time of presentation, and occasionally to delays in the initiation of antibiotic therapy. (See <a class="local">'Introduction'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Neurologic sequelae have been estimated to occur in half of the patients surviving bacterial meningitis. (See <a class="local">'Incidence'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Several features are associated with an unfavorable neurologic outcome: older age (&gt;65 years), hypotension, seizures, absence of otitis or sinusitis, alcoholism, tachycardia, lower score on the Glasgow Coma Scale, cranial nerve palsy, a cerebrospinal fluid white blood cell count of less than 1000 cells per microL, a positive blood culture, and a high serum C-reactive protein concentration. The rate of complications is greatest in pneumococcal meningitis. (See <a class="local">'Risk factors'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The neurologic complications of bacterial meningitis include (see <a class="local">'Neurologic complications'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Impaired mental status</p><p class="bulletIndent2"><span class="glyph">•</span>Increased intracranial pressure and cerebral edema</p><p class="bulletIndent2"><span class="glyph">•</span>Seizures</p><p class="bulletIndent2"><span class="glyph">•</span>Focal neurologic deficits (eg, cranial nerve palsy, hemiparesis)</p><p class="bulletIndent2"><span class="glyph">•</span>Cerebrovascular abnormalities</p><p class="bulletIndent2"><span class="glyph">•</span>Sensorineural hearing loss</p><p class="bulletIndent2"><span class="glyph">•</span>Intellectual impairment </p><p></p><p class="bulletIndent1">Neurologic complications can develop at any time during the course of bacterial meningitis. Impaired mental status is seen in most patients at presentation, and seizures are more often seen during the acute episode. Although also occurring early, sensorineural hearing loss is typically not appreciated until the patient has recovered from the acute illness. (See <a class="local">'Neurologic complications'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Concern about both the mortality and morbidity of bacterial meningitis has led to the administration of adjunctive <a class="drug drug_general" data-topicid="9334" href="/d/drug information/9334.html" rel="external">dexamethasone</a> in selected patients. The data supporting this approach and the indications for dexamethasone therapy are discussed separately. (See  <a class="medical medical_review" href="/d/html/1299.html" rel="external">"Dexamethasone to prevent neurologic complications of bacterial meningitis in adults"</a>.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Aronin SI, Peduzzi P, Quagliarello VJ. Community-acquired bacterial meningitis: risk stratification for adverse clinical outcome and effect of antibiotic timing. Ann Intern Med 1998; 129:862.</a></li><li><a class="nounderline abstract_t">de Gans J, van de Beek D, European Dexamethasone in Adulthood Bacterial Meningitis Study Investigators. Dexamethasone in adults with bacterial meningitis. N Engl J Med 2002; 347:1549.</a></li><li><a class="nounderline abstract_t">van de Beek D, de Gans J, Spanjaard L, et al. Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med 2004; 351:1849.</a></li><li><a class="nounderline abstract_t">Bijlsma MW, Brouwer MC, Kasanmoentalib ES, et al. Community-acquired bacterial meningitis in adults in the Netherlands, 2006-14: a prospective cohort study. Lancet Infect Dis 2016; 16:339.</a></li><li><a class="nounderline abstract_t">Lucas MJ, Brouwer MC, van de Beek D. Neurological sequelae of bacterial meningitis. J Infect 2016; 73:18.</a></li><li><a class="nounderline abstract_t">Bijlsma MW, Brouwer MC, Bossuyt PM, et al. Risk scores for outcome in bacterial meningitis: Systematic review and external validation study. J Infect 2016; 73:393.</a></li><li><a class="nounderline abstract_t">Domingo P, Pomar V, de Benito N, Coll P. The spectrum of acute bacterial meningitis in elderly patients. BMC Infect Dis 2013; 13:108.</a></li><li><a class="nounderline abstract_t">Tuomanen E, Hengstler B, Rich R, et al. Nonsteroidal anti-inflammatory agents in the therapy for experimental pneumococcal meningitis. J Infect Dis 1987; 155:985.</a></li><li><a class="nounderline abstract_t">Durand ML, Calderwood SB, Weber DJ, et al. Acute bacterial meningitis in adults. A review of 493 episodes. N Engl J Med 1993; 328:21.</a></li><li><a class="nounderline abstract_t">Tunkel AR, Scheld WM. Pathogenesis and pathophysiology of bacterial meningitis. Clin Microbiol Rev 1993; 6:118.</a></li><li><a class="nounderline abstract_t">Tureen JH, Dworkin RJ, Kennedy SL, et al. Loss of cerebrovascular autoregulation in experimental meningitis in rabbits. J Clin Invest 1990; 85:577.</a></li><li><a class="nounderline abstract_t">Goitein KJ, Tamir I. Cerebral perfusion pressure in central nervous system infections of infancy and childhood. J Pediatr 1983; 103:40.</a></li><li><a class="nounderline abstract_t">Zoons E, Weisfelt M, de Gans J, et al. Seizures in adults with bacterial meningitis. Neurology 2008; 70:2109.</a></li><li><a class="nounderline abstract_t">Feldman WE. Relation of concentrations of bacteria and bacterial antigen in cerebrospinal fluid to prognosis in patients with bacterial meningitis. N Engl J Med 1977; 296:433.</a></li><li><a class="nounderline abstract_t">Annegers JF, Hauser WA, Beghi E, et al. The risk of unprovoked seizures after encephalitis and meningitis. Neurology 1988; 38:1407.</a></li><li><a class="nounderline abstract_t">DODGE PR, SWARTZ MN. BACTERIAL MENINGITIS--A REVIEW OF SELECTED ASPECTS. II. SPECIAL NEUROLOGIC PROBLEMS, POSTMENINGITIC COMPLACATIONS AND CLINICOPATHOLOGICAL CORRELATIONS. N Engl J Med 1965; 272:954.</a></li><li><a class="nounderline abstract_t">Steven NM, Nathwani D. Facial palsy, meningococcal meningitis, and reactivation of herpes simplex virus. Clin Infect Dis 1993; 16:181.</a></li><li><a class="nounderline abstract_t">Pfister HW, Borasio GD, Dirnagl U, et al. Cerebrovascular complications of bacterial meningitis in adults. Neurology 1992; 42:1497.</a></li><li><a class="nounderline abstract_t">Schut ES, Lucas MJ, Brouwer MC, et al. Cerebral infarction in adults with bacterial meningitis. Neurocrit Care 2012; 16:421.</a></li><li><a class="nounderline abstract_t">Schut ES, Brouwer MC, de Gans J, et al. Delayed cerebral thrombosis after initial good recovery from pneumococcal meningitis. Neurology 2009; 73:1988.</a></li><li><a class="nounderline abstract_t">Gallegos C, Tobolowsky F, Nigo M, Hasbun R. Delayed Cerebral Injury in Adults With Bacterial Meningitis: A Novel Complication of Adjunctive Steroids? Crit Care Med 2018; 46:e811.</a></li><li><a class="nounderline abstract_t">Katchanov J, Heuschmann PU, Endres M, Weber JR. Cerebral infarction in bacterial meningitis: predictive factors and outcome. J Neurol 2010; 257:716.</a></li><li><a class="nounderline abstract_t">Gironell A, Domingo P, Mancebo J, et al. Hemorrhagic stroke as a complication of bacterial meningitis in adults: report of three cases and review. Clin Infect Dis 1995; 21:1488.</a></li><li><a class="nounderline abstract_t">Perry JR, Bilbao JM, Gray T. Fatal basilar vasculopathy complicating bacterial meningitis. Stroke 1992; 23:1175.</a></li><li><a class="nounderline abstract_t">Kaplan SL, Woods CR. Neurologic complications of bacterial meningitis in children. Curr Clin Top Infect Dis 1992; 12:37.</a></li><li><a class="nounderline abstract_t">Dodge PR, Davis H, Feigin RD, et al. Prospective evaluation of hearing impairment as a sequela of acute bacterial meningitis. N Engl J Med 1984; 311:869.</a></li><li><a class="nounderline abstract_t">Bhatt SM, Lauretano A, Cabellos C, et al. Progression of hearing loss in experimental pneumococcal meningitis: correlation with cerebrospinal fluid cytochemistry. J Infect Dis 1993; 167:675.</a></li><li><a class="nounderline abstract_t">Merchant SN, Gopen Q. A human temporal bone study of acute bacterial meningogenic labyrinthitis. Am J Otol 1996; 17:375.</a></li><li><a class="nounderline abstract_t">Kastenbauer S, Pfister HW. Pneumococcal meningitis in adults: spectrum of complications and prognostic factors in a series of 87 cases. Brain 2003; 126:1015.</a></li><li><a class="nounderline abstract_t">Worsøe L, Cayé-Thomasen P, Brandt CT, et al. Factors associated with the occurrence of hearing loss after pneumococcal meningitis. Clin Infect Dis 2010; 51:917.</a></li><li><a class="nounderline abstract_t">Klein M, Schmidt C, Kastenbauer S, et al. MyD88-dependent immune response contributes to hearing loss in experimental pneumococcal meningitis. J Infect Dis 2007; 195:1189.</a></li><li><a class="nounderline abstract_t">Hoogman M, van de Beek D, Weisfelt M, et al. Cognitive outcome in adults after bacterial meningitis. J Neurol Neurosurg Psychiatry 2007; 78:1092.</a></li><li><a class="nounderline abstract_t">van de Beek D, Schmand B, de Gans J, et al. Cognitive impairment in adults with good recovery after bacterial meningitis. J Infect Dis 2002; 186:1047.</a></li><li><a class="nounderline abstract_t">Weisfelt M, Hoogman M, van de Beek D, et al. Dexamethasone and long-term outcome in adults with bacterial meningitis. Ann Neurol 2006; 60:456.</a></li><li><a class="nounderline abstract_t">Kasanmoentalib ES, Brouwer MC, van der Ende A, van de Beek D. Hydrocephalus in adults with community-acquired bacterial meningitis. Neurology 2010; 75:918.</a></li><li><a class="nounderline abstract_t">Wang KW, Chang WN, Chang HW, et al. Clinical relevance of hydrocephalus in bacterial meningitis in adults. Surg Neurol 2005; 64:61.</a></li><li><a class="nounderline abstract_t">Bodilsen J, Schønheyder HC, Nielsen H. Hydrocephalus is a rare outcome in community-acquired bacterial meningitis in adults: a retrospective analysis. BMC Infect Dis 2013; 13:321.</a></li><li><a class="nounderline abstract_t">Seay AR. Spinal cord dysfunction complicating bacterial meningitis. Arch Neurol 1984; 41:545.</a></li><li><a class="nounderline abstract_t">Hughes DC, Raghavan A, Mordekar SR, et al. Role of imaging in the diagnosis of acute bacterial meningitis and its complications. Postgrad Med J 2010; 86:478.</a></li><li><a class="nounderline abstract_t">Ramos-Estebanez C, Yavagal D. Meningitis complicated by mycotic aneurysms. Oxf Med Case Reports 2014; 2014:40.</a></li></ol></div><div id="topicVersionRevision">Topic 1291 Version 26.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9867727" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Community-acquired bacterial meningitis: risk stratification for adverse clinical outcome and effect of antibiotic timing.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12432041" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Dexamethasone in adults with bacterial meningitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15509818" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Clinical features and prognostic factors in adults with bacterial meningitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26652862" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Community-acquired bacterial meningitis in adults in the Netherlands, 2006-14: a prospective cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27105658" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Neurological sequelae of bacterial meningitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27519619" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Risk scores for outcome in bacterial meningitis: Systematic review and external validation study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23446215" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : The spectrum of acute bacterial meningitis in elderly patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3470394" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Nonsteroidal anti-inflammatory agents in the therapy for experimental pneumococcal meningitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8416268" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Acute bacterial meningitis in adults. A review of 493 episodes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8472245" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Pathogenesis and pathophysiology of bacterial meningitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2105342" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Loss of cerebrovascular autoregulation in experimental meningitis in rabbits.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6864394" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Cerebral perfusion pressure in central nervous system infections of infancy and childhood.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18305232" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Seizures in adults with bacterial meningitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/13301" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Relation of concentrations of bacteria and bacterial antigen in cerebrospinal fluid to prognosis in patients with bacterial meningitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3412588" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : The risk of unprovoked seizures after encephalitis and meningitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14275833" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : BACTERIAL MENINGITIS--A REVIEW OF SELECTED ASPECTS. II. SPECIAL NEUROLOGIC PROBLEMS, POSTMENINGITIC COMPLACATIONS AND CLINICOPATHOLOGICAL CORRELATIONS.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8448306" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Facial palsy, meningococcal meningitis, and reactivation of herpes simplex virus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1641143" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Cerebrovascular complications of bacterial meningitis in adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21989842" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Cerebral infarction in adults with bacterial meningitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19890068" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Delayed cerebral thrombosis after initial good recovery from pneumococcal meningitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29746358" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Delayed Cerebral Injury in Adults With Bacterial Meningitis: A Novel Complication of Adjunctive Steroids?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19946782" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Cerebral infarction in bacterial meningitis: predictive factors and outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8749641" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Hemorrhagic stroke as a complication of bacterial meningitis in adults: report of three cases and review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1636194" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Fatal basilar vasculopathy complicating bacterial meningitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1353677" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Neurologic complications of bacterial meningitis in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6472398" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Prospective evaluation of hearing impairment as a sequela of acute bacterial meningitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8440938" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Progression of hearing loss in experimental pneumococcal meningitis: correlation with cerebrospinal fluid cytochemistry.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8817013" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : A human temporal bone study of acute bacterial meningogenic labyrinthitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12690042" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Pneumococcal meningitis in adults: spectrum of complications and prognostic factors in a series of 87 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20815735" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Factors associated with the occurrence of hearing loss after pneumococcal meningitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17357057" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : MyD88-dependent immune response contributes to hearing loss in experimental pneumococcal meningitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17353256" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Cognitive outcome in adults after bacterial meningitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12232850" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Cognitive impairment in adults with good recovery after bacterial meningitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16958121" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Dexamethasone and long-term outcome in adults with bacterial meningitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20820003" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Hydrocephalus in adults with community-acquired bacterial meningitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15993186" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Clinical relevance of hydrocephalus in bacterial meningitis in adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23855442" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Hydrocephalus is a rare outcome in community-acquired bacterial meningitis in adults: a retrospective analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6372757" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Spinal cord dysfunction complicating bacterial meningitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20709770" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Role of imaging in the diagnosis of acute bacterial meningitis and its complications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25988022" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Meningitis complicated by mycotic aneurysms.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
